title: Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial.
authors.affiliation: VA Medical Center, Minneapolis, MN, USA. ensru001@umn.edu
authors.forename: Kristine
authors.initials: K
authors.lastname: Ensrud
authors.forename: Andrea
authors.initials: A
authors.lastname: LaCroix
authors.forename: John R
authors.initials: JR
authors.lastname: Thompson
authors.forename: David D
authors.initials: DD
authors.lastname: Thompson
authors.forename: Richard
authors.initials: R
authors.lastname: Eastell
authors.forename: David M
authors.initials: DM
authors.lastname: Reid
authors.forename: Slobodan
authors.initials: S
authors.lastname: Vukicevic
authors.forename: Jane
authors.initials: J
authors.lastname: Cauley
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Barrett-Connor
authors.forename: Roisin
authors.initials: R
authors.lastname: Armstrong
authors.forename: Francine
authors.initials: F
authors.lastname: Welty
authors.forename: Steven
authors.initials: S
authors.lastname: Cummings